Medical information Clinical review pending

Genetic Testing

Hains Mycobacterium Tuberculosis Second Line Drug Resistance Profile Test

Detects resistance to second-line drugs in Mycobacterium tuberculosis, crucial for treating multidrug-resistant TB (MDR-TB). Helps guide effective therapy.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: 3 mL (minimum 2 mL) of sputum, bronchoalveolar lavage fluid, bronchial aspirate, or cultured growth on appropriate media.
Results: Confirm with the laboratory before booking.
Preparation: Collect the sample in a sterile, screw-capped container. Place the container within a sealed plastic bag. Ship the sample refrigerated. Do not freeze the sample. Confirm specific collection instructions with the laboratory before booking.

Test priceKSh 13,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Hains Mycobacterium Tuberculosis Second Line Drug Resistance Profile Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected multidrug-resistant tuberculosis (MDR-TB).
✓History of tuberculosis treatment failure.
✓Patients with symptoms suggestive of active TB (e.g., persistent cough, fever, night sweats, weight loss).
✓Individuals at high risk for drug-resistant TB.
✓Monitoring treatment response in patients with MDR-TB.
✓Patients with HIV co-infection and suspected TB.

In plain language

What this test helps you understand

This test identifies specific genetic mutations associated with resistance to second-line anti-TB drugs. It helps clinicians select appropriate drug regimens for patients with suspected or confirmed MDR-TB, optimizing treatment effectiveness and reducing the risk of treatment failure.

The Hains Mycobacterium Tuberculosis Second Line Drug Resistance Profile Test is a vital diagnostic tool used to identify resistance to second-line anti-tubercular drugs in Mycobacterium tuberculosis. This is particularly important for patients suspected of having multidrug-resistant TB (MDR-TB) or those who have previously failed TB treatment. Accurate detection of drug resistance allows healthcare providers to select the most effective treatment regimen, improving patient outcomes and helping to control the spread of drug-resistant TB. This test uses advanced molecular techniques for rapid and reliable results. We offer this test across Kenya, including Nairobi, Mombasa, and Kisumu, with home sample collection available.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationCollect the sample in a sterile, screw-capped container. Place the container within a sealed plastic bag. Ship the sample refrigerated. Do not freeze the sample. Confirm specific collection instructions with the laboratory before booking.

Sample3 mL (minimum 2 mL) of sputum, bronchoalveolar lavage fluid, bronchial aspirate, or cultured growth on appropriate media.

MethodologyMolecular diagnostic techniques, including PCR and line probe assays, are used to detect genetic mutations associated with resistance to second-line anti-tubercular drugs.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects resistance to specific second-line drugs based on known genetic markers. It may not detect all possible resistance mechanisms. Results should be interpreted in the context of the patient's clinical history and other diagnostic findings. Confirm with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

MDR-TB stands for Multidrug-Resistant Tuberculosis. It is a form of TB caused by bacteria that are resistant to at least two of the most powerful first-line anti-TB drugs.

Identifying resistance to second-line drugs is crucial for patients with MDR-TB, as these drugs are often the only effective treatment options. Knowing the resistance profile helps doctors choose the right combination of drugs.

The sample is typically sputum, but other samples like bronchoalveolar lavage fluid or bronchial aspirates can also be used. Your doctor will advise on the best method for sample collection.

Turnaround time varies. Please contact the laboratory for the most current estimated turnaround time.

We have branches across major cities in Kenya, including Nairobi, Mombasa, and Kisumu. We also offer home sample collection services. Contact us to confirm availability in your specific location.

The current price for this test is KSh 13,000. Please confirm pricing and any potential discounts when booking.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp